Martin ST - Search Results

1

Cytomegalovirus disease in lung transplantation: impact of recipient seropositivity and duration of antiviral prophylaxis.

Hammond SP, Martin ST, Roberts K, Gabardi S, Fuhlbrigge AL, Camp PC, Goldberg HJ, Marty FM, Baden LR. Hammond SP, et al. Among authors: martin st. Transpl Infect Dis. 2013 Apr;15(2):163-70. doi: 10.1111/tid.12036. Epub 2012 Dec 12. Transpl Infect Dis. 2013. PMID: 23230972

2

Evaluating the impact of pre-transplant desensitization utilizing a plasmapheresis and low-dose intravenous immunoglobulin protocol on BK viremia in renal transplant recipients.

Gabardi S, Townsend K, Martin ST, Chandraker A. Gabardi S, et al. Among authors: martin st. Transpl Infect Dis. 2013 Aug;15(4):361-8. doi: 10.1111/tid.12087. Epub 2013 May 6. Transpl Infect Dis. 2013. PMID: 23647907

3

Induction immunosuppressive therapies in renal transplantation.

Gabardi S, Martin ST, Roberts KL, Grafals M. Gabardi S, et al. Among authors: martin st. Am J Health Syst Pharm. 2011 Feb 1;68(3):211-8. doi: 10.2146/ajhp090636. Am J Health Syst Pharm. 2011. PMID: 21258026 Review.

4

Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation.

Gabardi S, Waikar SS, Martin S, Roberts K, Chen J, Borgi L, Sheashaa H, Dyer C, Malek SK, Tullius SG, Vadivel N, Grafals M, Abdi R, Najafian N, Milford E, Chandraker A. Gabardi S, et al. Clin J Am Soc Nephrol. 2010 Jul;5(7):1298-304. doi: 10.2215/CJN.08261109. Epub 2010 May 27. Clin J Am Soc Nephrol. 2010. PMID: 20507960 Free PMC article.

5

Atovaquone versus trimethoprim-sulfamethoxazole as Pneumocystis jirovecii pneumonia prophylaxis following renal transplantation.

Gabardi S, Millen P, Hurwitz S, Martin S, Roberts K, Chandraker A. Gabardi S, et al. Clin Transplant. 2012 May-Jun;26(3):E184-90. doi: 10.1111/j.1399-0012.2012.01624.x. Epub 2012 Apr 8. Clin Transplant. 2012. PMID: 22487221 Clinical Trial.

6

New England BK consortium: Regional survey of BK screening and management protocols in comparison to published consensus guidelines.

Gabardi S, Pavlakis M, Tan C, Francis J, Cardarelli F, Asch W, Bodziak K, Chobanian M, Gilligan H, Gohh R, Kung SC, Inker L, Martin S, Rodig N, Rossi A, Chandraker A. Gabardi S, et al. Transpl Infect Dis. 2018 Dec;20(6):e12985. doi: 10.1111/tid.12985. Epub 2018 Sep 19. Transpl Infect Dis. 2018. PMID: 30175491

7

Influenza in solid organ transplant recipients.

Martin ST, Torabi MJ, Gabardi S. Martin ST, et al. Ann Pharmacother. 2012 Feb;46(2):255-64. doi: 10.1345/aph.1Q436. Epub 2012 Jan 10. Ann Pharmacother. 2012. PMID: 22234989 Review.

8

Recommendations for the proper use of nonprescription cough suppressants and expectorants in solid-organ transplant recipients.

Gabardi S, Carter D, Martin S, Roberts K. Gabardi S, et al. Prog Transplant. 2011 Mar;21(1):6-13; quiz 14. doi: 10.1177/152692481102100102. Prog Transplant. 2011. PMID: 21485938 Review.

9

Induction treatment with rabbit antithymocyte globulin versus basiliximab in renal transplant recipients with planned early steroid withdrawal.

Martin ST, Roberts KL, Malek SK, Tullius SG, Vadivel N, De Serres S, Grafals M, Elsanjak A, Filkins BA, Chandraker A, Gabardi S. Martin ST, et al. Pharmacotherapy. 2011 Jun;31(6):566-73. doi: 10.1592/phco.31.6.566. Pharmacotherapy. 2011. PMID: 21923440

10

Belatacept: a novel biologic for maintenance immunosuppression after renal transplantation.

Martin ST, Tichy EM, Gabardi S. Martin ST, et al. Pharmacotherapy. 2011 Apr;31(4):394-407. doi: 10.1592/phco.31.4.394. Pharmacotherapy. 2011. PMID: 21449628 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

244 results

Search Page

Filters